PURPOSE: To identify associations between semiautomatically extracted MRI features and breast cancer molecular subtypes. METHODS: We analyzed routine clinical pre-operative breast MRIs from 275 breast cancer patients at a single institution in this retrospective, Institutional Review Board-approved study. Six fellowship-trained breast imagers reviewed the MRIs and annotated the cancers. Computer vision algorithms were then used to extract 56 imaging features from the cancers including morphologic, texture, and dynamic features. Surrogate markers (estrogen receptor [ER], progesterone receptor [PR], human epidermal growth factor receptor-2 [HER2]) were used to categorize tumors by molecular subtype: ER/PR+, HER2- (luminal A); ER/PR+, HER2+ (luminal B); ER/PR-, HER2+ (HER2); ER/PR/HER2- (basal). A multivariate analysis was used to determine associations between the imaging features and molecular subtype. RESULTS: The imaging features were associated with both luminal A (P = 0.0007) and luminal B (P = 0.0063) molecular subtypes. No association was found for either HER2 (P = 0.2465) or basal (P = 0.1014) molecular subtype and the imaging features. A P-value of 0.0125 (0.05/4) was considered significant. CONCLUSION: Luminal A and luminal B molecular subtype breast cancer are associated with semiautomatically extracted features from routine contrast enhanced breast MRI.
PURPOSE: To identify associations between semiautomatically extracted MRI features and breast cancer molecular subtypes. METHODS: We analyzed routine clinical pre-operative breast MRIs from 275 breast cancerpatients at a single institution in this retrospective, Institutional Review Board-approved study. Six fellowship-trained breast imagers reviewed the MRIs and annotated the cancers. Computer vision algorithms were then used to extract 56 imaging features from the cancers including morphologic, texture, and dynamic features. Surrogate markers (estrogen receptor [ER], progesterone receptor [PR], human epidermal growth factor receptor-2 [HER2]) were used to categorize tumors by molecular subtype: ER/PR+, HER2- (luminal A); ER/PR+, HER2+ (luminal B); ER/PR-, HER2+ (HER2); ER/PR/HER2- (basal). A multivariate analysis was used to determine associations between the imaging features and molecular subtype. RESULTS: The imaging features were associated with both luminal A (P = 0.0007) and luminal B (P = 0.0063) molecular subtypes. No association was found for either HER2 (P = 0.2465) or basal (P = 0.1014) molecular subtype and the imaging features. A P-value of 0.0125 (0.05/4) was considered significant. CONCLUSION: Luminal A and luminal B molecular subtype breast cancer are associated with semiautomatically extracted features from routine contrast enhanced breast MRI.
Authors: Ke Nie; Hania Al-Hallaq; X Allen Li; Stanley H Benedict; Jason W Sohn; Jean M Moran; Yong Fan; Mi Huang; Michael V Knopp; Jeff M Michalski; James Monroe; Ceferino Obcemea; Christina I Tsien; Timothy Solberg; Jackie Wu; Ping Xia; Ying Xiao; Issam El Naqa Journal: Int J Radiat Oncol Biol Phys Date: 2019-01-31 Impact factor: 7.038
Authors: Maciej A Mazurowski; Ashirbani Saha; Michael R Harowicz; Elizabeth Hope Cain; Jeffrey R Marks; P Kelly Marcom Journal: J Magn Reson Imaging Date: 2019-01-22 Impact factor: 4.813
Authors: SoHyun Han; Radka Stoyanova; Hansol Lee; Sean D Carlin; Jason A Koutcher; HyungJoon Cho; Ellen Ackerstaff Journal: Magn Reson Med Date: 2017-07-20 Impact factor: 4.668
Authors: Lars J Grimm; David Y Johnson; Karen S Johnson; Jay A Baker; Mary Scott Soo; E Shelley Hwang; Sujata V Ghate Journal: Eur Radiol Date: 2016-10-17 Impact factor: 5.315
Authors: Richard Ha; Simukayi Mutasa; Jenika Karcich; Nishant Gupta; Eduardo Pascual Van Sant; John Nemer; Mary Sun; Peter Chang; Michael Z Liu; Sachin Jambawalikar Journal: J Digit Imaging Date: 2019-04 Impact factor: 4.056